| Year |
Citation |
Score |
| 2022 |
Amin TU, Emara R, Pal A, Aldawod H, Jiang G, Liang D, Haque Tuhin MT, Balgoname A, Patel AD, Alhamadsheh MM. Enhancing the Safety and Efficacy of PSMA-Based Small-Molecule Drug Conjugates by Linker Stabilization and Conjugation to Transthyretin Binding Ligand. Journal of Medicinal Chemistry. PMID 36327103 DOI: 10.1021/acs.jmedchem.2c01423 |
0.689 |
|
| 2019 |
Pal A, Albusairi W, Liu F, Tuhin MTH, Miller M, Liang D, Joo H, Amin TU, Wilson EA, Faridi JS, Park M, Alhamadsheh MM. Hydrophilic Small Molecules that Harness Transthyretin to Enhance the Safety and Efficacy of Targeted Chemotherapeutic Agents. Molecular Pharmaceutics. PMID 31136717 DOI: 10.1021/Acs.Molpharmaceut.9B00432 |
0.7 |
|
| 2018 |
Miller M, Pal A, Albusairi W, Joo H, Pappas B, Haque Tuhin MT, Liang D, Jampala R, Liu F, Khan J, Faaij M, Park M, Chan W, Graef I, Zamboni R, et al. Enthalpy-Driven Stabilization of Transthyretin by AG10 Mimics a Naturally Occurring Genetic Variant That Protects from Transthyretin Amyloidosis. Journal of Medicinal Chemistry. PMID 30133284 DOI: 10.1021/Acs.Jmedchem.8B00817 |
0.676 |
|
| 2017 |
Alhamadsheh M, Miller M, Pal A, Albusairi W, Graef I, Sinha U, Fox J, Zamboni R, Kumar N. P5846AG10, an orally available, novel transthyretin (TTR) stabilizer: integrated preclinical evaluation predicts a highly effective treatment for TTR amyloid cardiomyopathy European Heart Journal. 38. DOI: 10.1093/Eurheartj/Ehx493.P5846 |
0.659 |
|
| 2015 |
Penchala SC, Miller MR, Pal A, Dong J, Madadi NR, Xie J, Joo H, Tsai J, Batoon P, Samoshin V, Franz A, Cox T, Miles J, Chan WK, Park MS, et al. A biomimetic approach for enhancing the in vivo half-life of peptides. Nature Chemical Biology. 11: 793-8. PMID 26344696 DOI: 10.1038/Nchembio.1907 |
0.519 |
|
| 2015 |
Penchala SC, Miller MR, Pal A, Dong J, Madadi NR, Xie J, Joo H, Tsai J, Batoon P, Samoshin V, Franz A, Cox T, Miles J, Chan WK, Park MS, et al. A biomimetic approach for enhancing the in vivo half-life of peptides Nature Chemical Biology. DOI: 10.1038/nchembio.1907 |
0.72 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2012 |
Pal A, Mahmud ZA, Akter N, Islam S, Bachar SC. Evaluation of Antinociceptive, Antidiarrheal and Antimicrobial Activities of Leaf Extracts of Clerodendrum indicum Polymer Journal. 4: 41-46. DOI: 10.5530/Pj.2012.30.8 |
0.221 |
|
| 2012 |
Sarker S, Pal A, Sultana J. Market Survey and Analysis of Packaging Information Provided by Different Pharmaceutical Companies of Bangladesh Bangladesh Pharmaceutical Journal. 15: 165-169. DOI: 10.3329/Bpj.V15I2.12585 |
0.215 |
|
| 2013 |
Manik MK, Wahid MA, Islam SMA, Pal A, Ahmed KT. A comparative study of the antioxidant, antimicrobial and thrombolytic activity of the bark and leaves of lannea coromandelica (anacardiaceae) International Journal of Pharmaceutical Sciences and Research. 4: 2609-2614. DOI: 10.13040/Ijpsr.0975-8232.4(7).2609-14 |
0.209 |
|
| 2013 |
Apu AS, Chowdhury FA, Khatun F, Jamaluddin ATM, Pathan AH, Pal A. Phytochemical Screening and In vitro Evaluation of Pharmacological Activities of Aphanamixis polystachya (Wall) Parker Fruit Extracts Tropical Journal of Pharmaceutical Research. 12: 111-116. DOI: 10.4314/Tjpr.V12I1.18 |
0.196 |
|
| 2024 |
Chen EC, Shapiro RL, Pal A, Bartee D, DeLong K, Carter DM, Serrano-Diaz E, Rais R, Ensign LM, Freel Meyers CL. Investigating inhibitors of 1-deoxy-d-xylulose 5-phosphate synthase in a mouse model of UTI. Microbiology Spectrum. e0389623. PMID 38376151 DOI: 10.1128/spectrum.03896-23 |
0.19 |
|
| 2024 |
Ranjit A, Lee CB, Tenora L, Mettu VS, Pal A, Alt J, Slusher BS, Rais R. Pharmacokinetic Evaluation of Neutral Sphinghomyelinase2 (nSMase2) Inhibitor Prodrugs in Mice and Dogs. Pharmaceutics. 17. PMID 39861669 DOI: 10.3390/pharmaceutics17010020 |
0.185 |
|
| 2022 |
Rais R, Lemberg KM, Tenora L, Arwood ML, Pal A, Alt J, Wu Y, Lam J, Aguilar JMH, Zhao L, Peters DE, Tallon C, Pandey R, Thomas AG, Dash RP, et al. Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug. Science Advances. 8: eabq5925. PMID 36383674 DOI: 10.1126/sciadv.abq5925 |
0.179 |
|
| 2022 |
Pal A, Gori S, Yoo SW, Thomas AG, Wu Y, Friedman J, Tenora L, Bhasin H, Alt J, Haughey N, Slusher BS, Rais R. Discovery of Orally Bioavailable and Brain-Penetrable Prodrugs of the Potent nSMase2 Inhibitor DPTIP. Journal of Medicinal Chemistry. PMID 35930706 DOI: 10.1021/acs.jmedchem.2c00562 |
0.178 |
|
| 2022 |
Tallon C, Bell BJ, Sharma A, Pal A, Malvankar MM, Thomas AG, Yoo SW, Hollinger KR, Coleman K, Wilkinson EL, Kannan S, Haughey NJ, Kannan RM, Rais R, Slusher BS. Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in Mice. Pharmaceutics. 14. PMID 36297501 DOI: 10.3390/pharmaceutics14102066 |
0.167 |
|
| 2021 |
Gao RD, Hin N, Prchalová E, Pal A, Lam J, Rais R, Slusher BS, Tsukamoto T. Model Studies towards Prodrugs of the Glutamine Antagonist 6-Diazo-5-oxo-L-norleucine (DON) Containing a Diazo Precursor. Bioorganic & Medicinal Chemistry Letters. 128321. PMID 34400301 DOI: 10.1016/j.bmcl.2021.128321 |
0.162 |
|
| 2025 |
Rudolph N, Charbe N, Plano D, Shoyaib AA, Pal A, Boyce H, Zhao L, Wu F, Polli J, Dressman J, Cristofoletti R. A physiologically based biopharmaceutics modeling (PBBM) framework for characterizing formulation-dependent food effects: paving the road towards fed virtual BE studies for itraconazole amorphous solid dispersions. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 107047. PMID 39983931 DOI: 10.1016/j.ejps.2025.107047 |
0.148 |
|
| 2023 |
Novotna K, Thomas AG, Stepanek O, Murphy B, Hin N, Skacel J, Mueller L, Tenora L, Pal A, Alt J, Wu Y, Paule J, Rais R, Slusher BS, Tsukamoto T. Neutral sphingomyelinase 2 inhibitors based on the pyrazolo[1,5-a]pyrimidin-3-amine scaffold. European Journal of Medicinal Chemistry. 259: 115674. PMID 37536209 DOI: 10.1016/j.ejmech.2023.115674 |
0.125 |
|
| 2021 |
Tallon C, Hollinger KR, Pal A, Bell BJ, Rais R, Tsukamoto T, Witwer KW, Haughey NJ, Slusher BS. Nipping disease in the bud: nSMase2 inhibitors as therapeutics in extracellular vesicle-mediated diseases. Drug Discovery Today. PMID 33798648 DOI: 10.1016/j.drudis.2021.03.025 |
0.11 |
|
| 2024 |
Pal A, Wu F, Walenga R, Tsakalozou E, Alam K, Gong Y, Zhao L, Fang L. Leveraging Modeling and Simulation to Enhance the Efficiency of Bioequivalence Approaches for Generic Drugs: Highlights from the 2023 Generic Drug Science and Research Initiatives Public Workshop. The Aaps Journal. 26: 45. PMID 38589695 DOI: 10.1208/s12248-024-00916-8 |
0.106 |
|
| 2023 |
Tallon C, Bell BJ, Malvankar MM, Deme P, Nogueras-Ortiz C, Eren E, Thomas AG, Hollinger KR, Pal A, Mustapic M, Huang M, Coleman K, Joe TR, Rais R, Haughey NJ, et al. Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in murine Alzheimer's disease. Research Square. PMID 37502930 DOI: 10.21203/rs.3.rs-3131295/v1 |
0.105 |
|
| 2022 |
Gori SS, Thomas AG, Pal A, Wiseman R, Ferraris DV, Gao RD, Wu Y, Alt J, Tsukamoto T, Slusher BS, Rais R. D-DOPA Is a Potent, Orally Bioavailable, Allosteric Inhibitor of Glutamate Carboxypeptidase II. Pharmaceutics. 14. PMID 36297453 DOI: 10.3390/pharmaceutics14102018 |
0.104 |
|
| 2021 |
Alt J, Gori SS, Lemberg KM, Pal A, Veeravalli V, Wu Y, Aguilar JMH, Dash RP, Tenora L, Majer P, Sun Q, Slusher BS, Rais R. Glutamine Antagonist GA-607 Causes a Dramatic Accumulation of FGAR Which Can be Used to Monitor Target Engagement. Current Drug Metabolism. PMID 34488583 DOI: 10.2174/1389200222666210831125041 |
0.093 |
|
| 2021 |
Tallon C, Picciolini S, Yoo SW, Thomas AG, Pal A, Alt J, Carlomagno C, Gualerzi A, Rais R, Haughey NJ, Bedoni M, Slusher BS. Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injury. Biochemical Pharmacology. 114796. PMID 34678224 DOI: 10.1016/j.bcp.2021.114796 |
0.084 |
|
| 2023 |
Tallon C, Bell BJ, Malvankar MM, Deme P, Nogueras-Ortiz C, Eren E, Thomas AG, Hollinger KR, Pal A, Mustapic M, Huang M, Coleman K, Joe TR, Rais R, Haughey NJ, et al. Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer's disease mouse model. Translational Neurodegeneration. 12: 56. PMID 38049923 DOI: 10.1186/s40035-023-00383-9 |
0.068 |
|
| 2017 |
Karim KB, Kumar NV, Raghupati B, Pal A. Effect of Biostimulants on Growth and Floral Attributes of Tuberose (Polianthes tuberosa L.). cv. Prajwal International Journal of Current Microbiology and Applied Sciences. 6: 2557-2564. DOI: 10.20546/IJCMAS.2017.606.304 |
0.03 |
|
| 2019 |
Parween N, Mishra S, Adil A, Pal A, Jha K. Effect of GA3 on Reproductive Growth and Cormel Production of Gladiolus International Journal of Current Microbiology and Applied Sciences. 8: 1739-1750. DOI: 10.20546/ijcmas.2019.806.208 |
0.025 |
|
| 2019 |
Parween N, Mishra S, Adil A, Pal A, Jha K. Effect of GA3 on Vegetative Growth and Sprouting in Gladiolus International Journal of Current Microbiology and Applied Sciences. 8: 2840-2857. DOI: 10.20546/IJCMAS.2019.807.355 |
0.024 |
|
| 2010 |
Barse AV, Chakrabarti T, Ghosh TK, Pal AK, Kumar N, Raman RP, Jadhao SB. Vitellogenin Induction and Histo-metabolic Changes Following Exposure of Cyprinus carpio to Methyl Paraben Asian-Australasian Journal of Animal Sciences. 23: 1557-1565. DOI: 10.5713/AJAS.2010.10118 |
0.01 |
|
| 2004 |
Barse AV, Jadhao SB, Sahu NP, Srivastava PP, Jain KK, Pal AK. Responses of Labeo rohita to Dietary Lathyrus sativus Seeds Asian-Australasian Journal of Animal Sciences. 17: 127-130. DOI: 10.5713/AJAS.2004.127 |
0.01 |
|
| Hide low-probability matches. |